The daily drug regimen known as PrEP is a nearly foolproof way to prevent HIV infection. But a new study suggests that many high-risk Americans may be giving the medication a pass because of cost.
Lack of Antigen Tests Has U.S. ‘Blind to Pandemic’
A KHN review found more than 20 states either don’t count or have incomplete data on the use of COVID-19 antigen tests, leaving the public in the dark about the true scope of the pandemic.
from WebMD Healthhttps://img.webm… Read MoreCoronavirus and Apartments: What’s the Risk?
The best advice for apartment and condo dwellers is what you already know: Wear a mask, wash your hands often, and keep your distance from others in highly trafficked common areas in your building.
from WebMD Healthhttps:/… Read MorePopular Prescription Will Increase Your COVID Hospital StayIn early 2020, a global pandemic spurred the world into action, especially in the science community. Researchers began seeking to discover how the COVID-19 virus worked and to uncover the best methods for testing, treating an… Read MoreCan a Parkinson's Drug Treat Macular Degeneration?
More than 15% of Americans over age 70 have AMD, and 10% to 15% of those cases go on to develop the more severe wet macular degeneration, which can cause swift and complete vision loss.
from WebMD Healthhttps://img.webmd.c… Read More
Global Uprising Underway
After six months of intermittent or in some cases near-continuous lockdowns, many have reached their limit and uprisings are finally emerging around the world. The last week of August 2020 saw gatherings of tens of thousands… Read More
0 comments:
Post a Comment